Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue engineering: the end of the beginning.

Michael J Lysaght1, Anne L Hazlehurst

  • 1Cemter for Biomedical Engineering, Brown University, Providence, Rhode Island, USA. Lysaght@Brown.edu

Tissue Engineering
|March 11, 2004
PubMed
Summary

The tissue engineering field faces economic challenges, with reduced R&D spending and market value. Despite significant investment, commercial success remains elusive, highlighting difficulties in transitioning from development to market.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Control of the timing and dosage of IGF-I delivery from encapsulated cells.

Journal of tissue engineering and regenerative medicine·2012
Same author

How to teach artificial organs.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2011
Same author

A localizable, biological-based system for the delivery of bioactive IGF-1 utilizing microencapsulated genetically modified human fibroblasts.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2009
Same author

Origins.

Tissue engineering. Part A·2009
Same author

Wearable artificial kidneys...2008. What's new?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2008
Same author

Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics.

Tissue engineering. Part A·2008

Area of Science:

  • Biotechnology and Regenerative Medicine
  • Medical Technology Assessment

Background:

  • The tissue engineering sector experienced significant growth prior to 2002.
  • Economic downturns and challenges in capital markets impact R&D-intensive industries.

Purpose of the Study:

  • To evaluate the economic impact on the tissue engineering field.
  • To analyze trends in employment, investment, and product development.

Main Methods:

  • Data collection from active firms across 15 countries.
  • Comparative analysis of data from 1995, 1998, 2000, and 2002.
  • Assessment of financial performance and product pipeline status.

Main Results:

  • Global FTEs in tissue engineering reached over 2600 by end of 2002, with annual spending at $487 million (down 20% since 2000).
  • Significant decline in structural tissue applications (skin, cartilage) by over 50%, offset by a 42% rise in stem cell firms.
  • Market capitalization of public tissue engineering firms dropped 90% to $300 million; only 4 of 20 products in FDA trials achieved approval, none commercially successful.

Conclusions:

  • Tissue engineering struggles to transition from R&D to commercial viability.
  • Breakthrough medical technologies face inherent challenges in market development.
  • Continued investment is needed, alongside strategies to overcome commercialization hurdles.

Related Experiment Videos